FORM OF LOCK-UP LETTERLock-Up Agreement • January 10th, 2013 • Baker Julian • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 10th, 2013 Company IndustryThe undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Synageva BioPharma Corp., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including Morgan Stanley (the “Underwriter”), of shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”).
LOCK-UP LETTER July 9, 2012Lock-Up Agreement • July 20th, 2012 • Baker Julian • Biological products, (no disgnostic substances)
Contract Type FiledJuly 20th, 2012 Company IndustryThe undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Synageva BioPharma Corp., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including Morgan Stanley (the “Underwriter”), of shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”).